Skip to main content
logo
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
702.05
+43.85 (6.66%)
Jul 10, 2026, 3:49 PM IST

NSE:AKUMS Revenue

In the fiscal year ending March 31, 2026, Akums Drugs and Pharmaceuticals had annual revenue of 43.61B INR with 5.84% growth. Akums Drugs and Pharmaceuticals had revenue of 11.60B in the quarter ending March 31, 2026, with 9.63% growth.

Revenue
43.61B
Revenue Growth
+5.84%
P/S Ratio
2.46
Revenue / Employee
5.94M
Employees
7,337
Market Cap
107.47B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202643.61B2.40B5.84%
Mar 31, 202541.21B-607.25M-1.45%
Mar 31, 202441.82B5.24B14.34%
Mar 31, 202336.57B-180.32M-0.49%
Mar 31, 202236.75B9.49B34.81%
Mar 31, 2021 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Alembic Pharmaceuticals73.45B
Strides Pharma Science48.59B
NATCO Pharma40.78B
Eris Lifesciences31.15B
Alivus Life Sciences25.52B
Cohance Lifesciences22.69B
Aarti Pharmalabs18.19B
Innova Captab16.30B
Revenue Rankings

Akums Drugs and Pharmaceuticals News

More News